We constructed the AMPK overexpression group and the HNF4α inhibition group by lateral ventricle injection of AICAR and BI6015 (an HNF4α inhibitor) and determined the three-day neurological function score (Fig. 2A) after CA/ROSC. The gene discussed is HNF4A; the disease is cancer.